A Randomized Phase 3 Trial Of Melphalan-Lenalidomide-Prednisone (MPR) Or Cyclophosphamide-Prednisone-Lenalidomide (CPR) Vs Lenalidomide Plus Dexamethsone (Rd) In Elderly Newly Diagnosed Multiple Myeloma Patients

被引：5
|
作者：
Palumbo, Antonio
Magarotto, Valeria
Bringhen, Sara
Offidani, Massimo
Pietrantuono, Giuseppe
Liberati, Anna Marina
Benevolo, Giulia
Ledda, Antonio
Gilestro, Milena
Galli, Monica
Patriarca, Francesca
Genuardi, Mariella
Giuliani, Nicola
Zambello, Renato
Zdenek, Adam
La Fauci, Alessia
Corradini, Paolo
Falcone, Antonietta Pia
Musolino, Caterina
Rossi, Davide
Caraffa, Patrizia
Musto, Pellegrino
Cavallo, Federica
Hajek, Roman
Boccadoro, Mario
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.536.536
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
536
引用
收藏
页数：2
相关论文
共 50 条
  • [21] LENALIDOMIDE plus LOW-DOSE DEXAMETHASONE (RD) VS. MELPHALAN-PREDNISONE-THALIDOMIDE (MPT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS (PTS): THE FIRST TRIAL
    Facon, T.
    Dimopoulos, M. A.
    Dispenzieri, A.
    Catalano, J. V.
    Belch, A.
    Hulin, C.
    Cavo, M.
    Pinto, A.
    Weisel, K. C.
    Ludwig, H.
    Bahlis, N.
    Banos, A.
    Tiab, M.
    Delforge, M.
    Cavenagh, J.
    Geraldes, C.
    Lee, J. J.
    Chen, C.
    Oriol, A.
    De La Rubia, J.
    Qiu, L.
    White, D.
    Binder, D.
    Anderson, K. C.
    Moreau, P.
    Attal, M.
    Knight, R.
    Chen, G.
    Van Oostendorp, J.
    Jacques, C. J.
    Ervin-Haynes, A.
    Benboubker, L.
    HAEMATOLOGICA, 2014, 99 : 220 - 221
  • [22] Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma:: A report from the GIMEMA -: Italian multiple myeloma network
    Palumbo, Antonio
    Falco, Patrizia
    Corradini, Paolo
    Falcone, Antonietta
    Di Raimondo, Francesco
    Giuliani, Nicola
    Crippa, Claudia
    Ciccone, Giovannino
    Omede, Paola
    Ambrosini, Maria Teresa
    Gay, Francesca
    Bringhen, Sara
    Musto, Pellegrino
    Foa, Robin
    Knight, Robert
    Zeldis, Jerome B.
    Boccadoro, Mario
    Petrucci, Maria Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) : 4459 - 4465
  • [23] MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma
    Cook, Gordon
    Zamagni, Elena
    Boccadoro, Mario
    Spencer, Andrew
    Delforge, Michel
    Reece, Donna
    Szabo, Agoston Gyula
    Einsele, Hermann
    Terpos, Evangelos
    Schjesvold, Fredrik
    Bila, Jelena
    Driessen, Christoph
    Beksac, Meral
    Rodriguez, Cesar
    Pei, Lixia
    Shi, Yingqi
    Sakabedoyan, Caline
    Jasielec, Jagaoda
    Amin, Himal
    Kobos, Rachel
    Sonneveld, Pieter
    Van De Donk, Niels
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 57 - 57
  • [24] MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSUS HIGH-DOSE MELPHALAN AND AUTOLOGOUS TRANSPLANTATION (MEL200) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS
    Palumbo, A.
    Cavallo, F.
    Gay, F.
    di Toritto, T.
    Cavalli, M.
    Ben Yehuda, D.
    Finsinger, P.
    Rossi, G.
    Rocci, A.
    Siniscalchi, A.
    Barbarano, L.
    Carella, A.
    Catalano, L.
    Musto, P.
    Cerrato, C.
    Marcatti, M.
    Cavo, M.
    Patriarca, F.
    Genuardi, M.
    Redoglia, V.
    Rossini, F.
    Corradini, P.
    Nagler, A.
    Di Raimondo, F.
    Hardan, I.
    Boccadoro, M.
    HAEMATOLOGICA, 2013, 98 : 96 - 96
  • [25] Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide
    Palumbo, A.
    Rus, C.
    Zeldis, J. B.
    Rodeghiero, F.
    Boccadoro, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (08) : 1842 - 1845
  • [26] Autologous Transplantation Versus Cyclophosphamide-Lenalidomide-Prednisone Followed By Lenalidomide-Prednisone Versus Lenalidomide Maintenance in Multiple Myeloma: Long-Term Results of a Phase Ill Trial
    Gay, Francesca
    Magarotto, Valeria
    Petrucci, Maria Teresa
    Di Raimondo, Francesco
    Pour, Ludek
    Caravita, Tommaso
    Scudla, Vlastimil
    Cafro, Anna Maria
    Liberati, Anna Marina
    Spada, Stefano
    Vladimir, Maisnar
    Pescosta, Norbert
    Ria, Roberto
    Offidani, Massimo
    Bringhen, Sara
    Bernardini, Annalisa
    Patriarca, Francesca
    Corradini, Paolo
    Foa, Roberto
    Cascavilla, Nicola
    Catalano, Lucio
    Spencer, Andrew
    Hajek, Roman
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2015, 126 (23)
  • [27] Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial
    Dimopoulos, Meletios A.
    Delforge, Michel
    Hajek, Roman
    Kropff, Martin
    Petrucci, Maria T.
    Lewis, Philip
    Nixon, Annabel
    Zhang, Jingshan
    Mei, Jay
    Palumbo, Antonio
    HAEMATOLOGICA, 2013, 98 (05) : 784 - 788
  • [28] Comparison Of Sequential Vs Alternating Administration Of Bortezomib, Melphalan and Prednisone (VMP) and Lenalidomide Plus Dexamethasone (Rd) In Elderly Patients With Newly Diagnosed Multiple Myeloma (MM) Patients: GEM2010MAS65 Trial
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Hernandez, Miguel T.
    Martinez, Rafael
    Rosinol, Laura
    Ocio, Enrique M.
    Echeveste, Maria Asuncion
    de Oteyza, Jaime Perez
    Oriol, Albert
    Joan, Bargay
    Mercedes, Gironella
    Martin, Jesus
    Cabrera, Carmen
    Gutierrez, Norma
    Luisa, Martin Maria
    de la Rubia, Javier
    Blade, Joan
    Lahuerta, Juan Jose
    San Miguel, Jesus F.
    BLOOD, 2013, 122 (21)
  • [29] Melphalan (M), prednisone (P) and lenalidomide (R) combination (MPR) for newly diagnosed multiple myeloma patients who are not candidates for stem cell transplantation.
    Roy, Vivek
    Leif, Bergsagel P.
    Jacob, Allred
    Philip, Greipp R.
    BLOOD, 2006, 108 (11) : 1016A - 1016A
  • [30] A PHASE 3 STUDY TO DETERMINE THE EFFICACY AND SAFETY OF LENALIDOMIDE COMBINED WITH MELPHALAN AND PREDNISONE IN PATIENTS=65 YEARS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
    Palumbo, A.
    Dimopoulos, M.
    Delforge, M.
    Hajek, R.
    Kropff, M.
    Petrucci, M. T.
    Yu, Z.
    Herbein, L.
    Mei, J.
    Jacques, C.
    Catalano, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 234 - 235
12345